ISRAEL: Patients suffering from fibromyalgia frequently use cannabis to treat chronic pain and other symptoms of the disease, according to data published in the journal Pain Research and Treatment. Israeli researchers surveyed over 2,700 fibromyalgia patients. Of those who responded to the questionnaire, 84 percent reported consuming cannabis.
“Pain relief was reported by 94 percent of cannabis consumers, while 93 percent reported improved sleep quality, 87 percent reported improvement in depression, and 62 percent reported improvement in anxiety,” authors concluded. In addition, “nearly 85 percent of the patients either completely stopped taking any other pain medications or reduced the dosage of other meds. This reflects the advantage of cannabis over other meds in alleviating pain in addition to its favorable effects on sleep and mood.”
For more information, contact Paul Armentano, NORML Deputy Director, at: firstname.lastname@example.org. Full text of the study, “The consumption of cannabis by fibromyalgia patients in Israel,” appears in Pain Research and Treatment.